Nasacort AQ

Nasacort AQ

triamcinolone acetonide

Manufacturer:

sanofi-aventis

Distributor:

DKSH
Concise Prescribing Info
Contents
Triamcinolone acetonide
Indications/Uses
Symptomatic treatment of seasonal & perennial allergic rhinitis in adult & childn ≥2 yr.
Dosage/Direction for Use
Adult & childn ≥12 yr 220 mcg (2 sprays in each nostril) once daily. Maintenance: 110 mcg (1 spray in each nostril) once daily, 6-12 yr 110 mcg (1 spray in each nostril) once daily. Max: 220 mcg (2 sprays in each nostril) once daily, 2-5 yr Max: 110 mcg (1 spray in each nostril) once daily.
Special Precautions
Discontinue use if localized nose & pharynx infections develop. Recent nasal septal ulcers, surgery or trauma. Cushing's syndrome, Cushingoid features, adrenal suppression, cataract, glaucoma, psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression. Visual disturbance. Transferring patients from systemic treatment. Additional therapy during period of stress or elective surgery. High doses & prolonged use. May cause skin irritation due to benzalkonium Cl. Closely monitor patients w/ change in vision or history of IOP, glaucoma &/or cataracts. Pregnancy & lactation. Growth retardation in childn & adolescents. Not recommended in childn <2 yr.
Adverse Reactions
Flu syndrome, pharyngitis, rhinitis; headache; bronchitis, epistaxis, cough, pharyngolaryngeal pain; dyspepsia, tooth disorder, upper abdominal pain, diarrhea; excoriation.
ATC Classification
R01AD11 - triamcinolone ; Belongs to the class of topical corticosteroids used for prophylaxis and treatment of allergic rhinitis.
Presentation/Packing
Form
Nasacort AQ nasal spray 55 mcg/spray
Packing/Price
120 dose x 1's;30 dose x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in